Cancer Clinical Investigation

Search results

• Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study

  Llovet, J.

  9/01/25

  1 item of Media coverage

  Press/Media

• Combination treatment for liver cancer significantly improves progression-free survival in global trial

  Llovet, J.

  9/01/25

  1 item of Media coverage

  Press/Media

• Mount Sinai: Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study

  Llovet, J.

  9/01/25

  1 item of Media coverage

  Press/Media

• Global Trial Shows Major Boost in Liver Cancer Treatment Success

  Llovet, J.

  9/01/25

  1 item of Media coverage

  Press/Media

• An international study led by a researcher from IDIBAPS-Hospital Clínic Barcelona demonstrates the first significant improvement in the treatment of a subtype of liver cancer in twenty years

  Llovet, J.

  9/01/25

  1 item of Media coverage

  Press/Media

• Lancet study has hope for liver cancer: Immunotherapy drug can delay progression in patients who can’t be treated with surgery

  Llovet, J.

  9/01/25

  1 item of Media coverage

  Press/Media

• Lancet study has hope for liver cancer: Immunotherapy drug can delay progression in patients who can't be treated with surgery

  Llovet, J.

  9/01/25

  1 item of Media coverage

  Press/Media

• New Lung Cancer Data Have Been Reported by Researchers at Department of Radiation Oncology [Lung-map Next-generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (Swog S1400)]

  Hirsch, F. & Hirsch, F.

  8/01/25

  1 item of Media coverage

  Press/Media

• An international study led by the Clínic improves liver cancer treatment

  Llovet, J.

  8/01/25

  1 item of Media coverage

  Press/Media

• Woman, 27, is diagnosed with breast cancer just 2 weeks before her sister, 32, receives the same diagnosis

  Tiersten, A.

  7/01/25

  2 items of Media coverage

  Press/Media

• Woman, 27, is diagnosed with breast cancer just 2 weeks before her sister, 32, receives the same diagnosis

  Tiersten, A.

  7/01/25

  1 item of Media coverage

  Press/Media

• How many alcoholic drinks can I have a week without increasing my cancer risk?

  Sparano, J.

  7/01/25

  2 items of Media coverage

  Press/Media

• How many alcoholic drinks can I have a week without increasing my cancer risk?

  Sparano, J.

  7/01/25

  1 item of Media coverage

  Press/Media

• Lenvatinib-pembrolizumab plus TACE promising for intermediate-stage liver cancer

  Llovet, J.

  7/01/25

  1 item of Media coverage

  Press/Media

• AI Tool Democratizes Cancer Immunotherapy Access

  Samstein, R., Marron, T. & Chowell, D.

  7/01/25

  1 item of Media coverage

  Press/Media

• Woman, 27, is diagnosed with breast cancer just 2 weeks before her sister, 32, receives the same diagnosis

  Tiersten, A.

  7/01/25

  1 item of Media coverage

  Press/Media

• Woman, 27, is diagnosed with breast cancer just 2 weeks before her sister, 32, receives the same diagnosis

  Tiersten, A.

  6/01/25

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Create AI Tool to Democratize Access to Cancer Immunotherapy

  Samstein, R., Marron, T. & Chowell, D.

  6/01/25

  1 item of Media coverage

  Press/Media

• How many alcoholic drinks can I have a week without increasing my cancer risk?

  Sparano, J.

  6/01/25

  11 items of Media coverage

  Press/Media

• Karyopharm Therapeutics falls 25% in past year

  Mascarenhas, J.

  6/01/25

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Create AI Tool to Democratize Access to Cancer Immunotherapy

  Samstein, R., Marron, T. & Chowell, D.

  6/01/25

  1 item of Media coverage

  Press/Media

• John O. Mascarenhas, MD, on Relapsed/Refractory Myelofibrosis: Navtemadlin vs Best Available Therapy After JAK Inhibitor Treatment

  Mascarenhas, J.

  4/01/25

  1 item of Media coverage

  Press/Media

• John O. Mascarenhas, MD, on Myelofibrosis: Novel Combination of Imetelstat Plus Ruxolitinib

  Mascarenhas, J.

  4/01/25

  1 item of Media coverage

  Press/Media

• Weekly: Karyopharm Therapeutics (KPTI: 77.0c) surges 10% on below average volume; +7c [10.0%]

  Mascarenhas, J.

  4/01/25

  1 item of Media coverage

  Press/Media

• Managing Treatment-Emergent Anemia in a Patient With Myelofibrosis

  Mascarenhas, J.

  4/01/25

  1 item of Media coverage

  Press/Media